Medium materiality6/10
Pharvaris price target raised to $40 from $39 at Guggenheim
Why it may matterVerify against the original reporting
Guggenheim bullish.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises PHVS target to $40 from $39; current price $36.46; -6.64% since signal.
- Target $40; price $36.46; Guggenheim raises target.
Key facts
- 01
Target: $40
- 02
Posted price: $36.46
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.